The natural history of multiple sclerosis: A geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis

Brain

Volumn 122, Issue 4, 1999, Pages 625-639

  Cottrell, D A ^a   Kremenchutzky, M ^a   Rice, G P A ^a   Koopman, W J ^a   Hader, W ^a   Baskerville, J ^a   Ebers, G C ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b London Hlth Sci Ctr Univ Campus ^*  (Canada)

Author keywords

Natural history; Outcome; Primary progressive multiple sclerosis; Prognosis; Progression rate

Indexed keywords

ADULT; ARTICLE; CLINICAL FEATURE; DEATH; DETERIORATION; DISEASE CLASSIFICATION; DISEASE COURSE; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE SCLEROSIS; ONSET AGE; PHYSICAL DISABILITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; SEX DIFFERENCE;

ADULT; AGE DISTRIBUTION; AGE OF ONSET; AMBULATORY CARE FACILITIES; COHORT STUDIES; DISABILITY EVALUATION; DISEASE PROGRESSION; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIPLE SCLEROSIS; ONTARIO; PROGNOSIS; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0032946328     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/122.4.625     Document Type: Article

References (33)

1. Bonduelle M, Albaranes R. Etude statistique de 145 cas de la sclerose en plaque. Sem Hop Paris 1962; 38: 3762-73.
2. Charcot JM. Disseminated sclerosis: its symptomatology. In: Charcot JM. Lectures on the diseases of the nervous system. London: New Syndenham Society; 1877. p. 209-17.
3. Confavreux C. Aimard G, Devic M. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients. Brain 1980; 103: 281-300.
4. Cottrell DA, Kremenchutzky M, Rice GPA, Hader W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 6. Applications to planning and interpretation of clinical therapeutic trials in primary progressive multiple sclerosis. Brain 1999; 122: 641-7.
5. Ebers GC, Paty DW. Natural history studies and applications to clinical trials. In: Paty DW, Ebers GC, editors. Multiple sclerosis. Philadelphia: F. A. Davis; 1998. p. 192-228.
6. Hader WJ, Elliot M, Ebers GC. Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology 1988; 38: 617-21.
7. Hyllested K. Lethality, duration and mortality of disseminated sclerosis in Denmark. Acta Psych Neuro Scand 1961; 36: 553-64.
8. Kremenchutzky M, Baskerville J, Cottrell DA, Rice GPA, Ebers GC. Progressive-relapsing and relapsing-progressive multiple sclerosis: a reevaluation [abstract]. Multiple Sclerosis 1998; 4: 372.
9. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907-11.
10. Minderhoud JM, van der Hoeven JH, Prange AJ. Course and prognosis of chronic progressive multiple sclerosis. Results of an epidemiological study. Acta Neurol Scand 1988; 78: 10-5.
11. Nelson LM, Franklin GM, Jones MC. Risk of multiple sclerosis exacerbation during pregnancy and breast-feeding. J Am Med Assoc 1988; 259: 3441-3.
12. Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 1994; 44:16-20.
13. Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Moller E, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989; 86: 7113-7.
14. Patzold U, Pocklington PR. Course of multiple sclerosis. First results of a prospective study carried out on 102 multiple sclerosis patients from 1976-1980. Acta Neurol Scand 1982; 65: 248-66.
15. Phadke JG. Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland. J Neurol Neurosurg Psychiatry 1987; 50: 523-31.
16. Poser S, Poser W, Schlaf G, Firnhaber W, Lauer K, Wolter M, et al. Prognostic indicators in multiple sclerosis. Acta Neurol Scand 1986; 74: 387-92.
17. Poser S, Kurtzke JF, Poser W, Schlaf G. Survival in multiple sclerosis. J Clin Epidemiol 1989; 42: 159-68.
18. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 1994; 117: 759-65.
19. Robertson NP, Clayton D, Fraser M, Deans J, Compston DA. Clinical concordance in sibling pairs with multiple sclerosis. Neurology 1996; 47: 347-52.
20. Runmarker B, Andersen O. Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up. Brain 1993; 116: 117-34.
21. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis [see comments]. Brain 1995; 118: 253-61. Comment in: Brain 1995; 118: 1617-8.
22. Runmarker B, Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis [see comments]. Brain 1995; 118: 253-61. Comment in: Brain 1995; 118: 1617-8.
23. Sackett DL, Haynes RB, Tugwell P. Making a prognosis. In: Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown; 1985. p. 159-69.
24. Shepherd DI, Downie AW. A further prevalence study of multiple sclerosis in north-east Scotland. J Neurol Neurosurg Psychiatry 1980; 43: 310-5.
25. Thompson AJ, Kermode AG, MacManus DG, Kingsley DP, Kendall BE, Moseley IF, et al. Pathogenesis of progressive multiple sclerosis [letter]. Lancet 1989; 1: 1322-3.
26. Verdru P, Theys P, D'Hooghe MB. Carton H. Pregnancy and multiple sclerosis: the influence on long term disability. Clin Neurol Neurosurg 1994; 96: 38-41.
27. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 1989a; 112: 133-46.
28. Weinshenker BG, Bass B, Rice GP, Noseworthy J, Carriere W, Baskerville J, et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989b; 112: 1419-28.
29. Weinshenker BG, Bulman D, Carriere W, Baskerville J. Ebers GC. A comparison of sporadic and familial multiple sclerosis. Neurology 1990; 40: 1354-8.
30. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome. Brain 1991a; 114: 1045-56.
31. Weinshenker BG, Rice GP, Noseworthy JH, Carriere W, Baskerville J, Ebers GC. The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. Brain 1991b; 114: 1057-67.
32. Whitacre CC, Blankenhorn E, Brinley FJ, Collier E, Duquette P, Fox H, et al. Sex differences in autoimmune disease: focus on multiple sclerosis. Science. In press 1999.
33. Worthington J, Jones R, Crawford M, Forti A. Pregnancy and multiple sclerosis - a 3-year prospective study. J Neurol 1994; 241: 228-33.